Robin L Jones

73PUBLICATIONS
279CO-AUTHORS
Molecular targetsComparative language studiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyGlobalisation and culture
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (73)

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|May 04, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

|Apr 24, 2026
In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Mar 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Mrinal Gounder, Patrick Schöffski, Robin L Jones

|Jan 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Robin L Jones, Roman Groisberg, Jean-Yves Blay

|Jun 11, 2025
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions.

Stefania Kokkali, Ana Dolcan, Kjetil Boye

Pageof 13

Frequent Collaborators

19 joint publications

Paul Huang

12 joint publications

Jean-Yves Blay

8 joint publications

Sebastian Bauer

8 joint publications

Michael C Heinrich